Clinical trial
A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors
NCT00276913 · Synta Pharmaceuticals Corp., Industry · Completed
Key facts
| NCT number | NCT00276913 |
|---|---|
| Title | A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors |
| Official title | A Phase I Study of STA-5312 Administered Weekly in Subjects With Advanced or Metastatic Solid Tumors |
| Lead sponsor | Synta Pharmaceuticals Corp., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Advanced or Metastatic Solid Tumors |
| Intervention type | Drug |
| Interventions | STA-5312 |
| Enrollment | 30 |
| Start date | Jun 1, 2004 |
| First posted | Jan 13, 2006 |
| Last update posted | Feb 3, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: